Abstract
The emergence of Multiple Drug Resistance (MDR), a consequence of the exorbitant use of antibiotics, allied with the pharmaceutical industry's lack of investment in the discovery of new drugs, has resulted in a worldwide alert due to the scarcity of therapeutic options for bacterial infections. In this scenario, interests in the search for new antimicrobial compounds increases. Given the …